key: cord-0828691-ncfnh3dl authors: Canarutto, Daniele; Del Barba, Paolo; Di Frenna, Marianna; Del Tedesco, Federica; Pajno, Roberta; Guarneri, Maria Pia; Barera, Graziano title: Prolonged asymptomatic SARS‐CoV‐2 infection in a child receiving immunosuppressive therapy date: 2020-07-31 journal: Pediatr Pulmonol DOI: 10.1002/ppul.24983 sha: 503dd66757e3ba658b71ccd3bff52bd25240cd62 doc_id: 828691 cord_uid: ncfnh3dl nan To the Editor, The current coronavirus disease 2019 (COVID-19) pandemic burden is the product of the high infectivity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), variable clinical presentation, and high lethality of the disease. Children are relatively spared by the disease, but there is increasing concern regarding their role in the chain of contagion, 1 and little data is available concerning the course of COVID-19 in children receiving immunosuppressive agents. We report a case of familial transmission of SARS-CoV-2 whereby a girl became infected while receiving immunosuppressive therapy; while she did not display any symptom or sign of disease, more than 30 days passed before she eventually tested negative. Her father, a 46-year-old hospital employee, not involved in patient care, developed fever, cough, and rhinitis on 22nd March. As illustrated in Figure 1 Brief report: International perspectives on the pediatric COVID-19 experience COVID-19 cardiac involvement in a 38-day old infant Favourable outcome of coronavirus-19 in a 1-year-old girl with acute myeloid leukaemia and severe treatment-induced immunosuppression The isolation period should be longer: Lesson from a child infected with SARS-CoV-2 in Chongqing home-care-for-patients-with-suspected-novelcoronavirus-(ncov)-infection-presenting-with-mild-symptoms-andmanagement-of-contacts